The 3D multiomic determinants of prostate cancer lethality

Active Project Grant Awarded

Award ID
HT9425261E158
Recipient
Awarding agency
Obligated
$1,698,858

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 18% complete
Place of performance
Los Angeles, CA 90024, USA

Award details come from USAspending.gov.

About this award

The Defense Health Agency awarded Project Grant HT9425261E158 to University of California, Los Angeles, acting through its Office of Research Administration, obligating $1.698858 million on May 7, 2026, under Military Medical Research and Development (Assistance Listing 12.420). The award funds research on the 3D multiomic determinants of prostate cancer lethality, with an ultimate completion date of May 31, 2029, and performance in Los Angeles, California 90024.

The sub-award HT9425261E158-14400000589772, dated September 4, 2026, passes work to Sanford Burnham Prebys Medical Discovery Institute. The subrecipient contributes to two aims: delineating subclonal methylome-genome heterogeneity across a large cohort of prostate tumors using single-cell 3D multi-omics, and developing a single-cell 3D multi-omic prognostic marker for the lethality of localized prostate cancer.

Subawards

Subrecipient Amount Awarded
Sanford Burnham Prebys Medical Discovery Institute Subrecipient will contribute to the following Aims: 1) Specific Aim 1: Delineate the subclonal methylome-genome heterogeneity in a large cohort of prostate… $169,207

Quick answers

Who received award HT9425261E158?

HT9425261E158 was awarded to University Of California, LOS Angeles by Defense Health Agency (Department of Defense) on May 7, 2026.

How much is award HT9425261E158 worth?

$1,698,858 has been obligated on HT9425261E158.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award